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Abstract
Background: Bronchoalveolar stem cells (BASCs) located in the bronchoalveolar duct junction are thought to regenerate
both bronchiolar and alveolar epithelium during homeostatic turnover and in response to injury. The mechanisms directing





2) were isolated from adult mouse lung using FACS, and their capacity
for self-renewal and differentiation were demonstrated by immunostaining. A transcription factor network of 53 genes
required for pluripotency in embryonic stem cells was assessed in BASCs, Kras-initiated lung tumor tissue, and lung
organogenesis by real-time PCR. c-Myc was knocked down in BASCs by infection with c-Myc shRNA lentivirus.
Comprehensive miRNA and mRNA profiling for BASCs was performed, and significant miRNAs and mRNAs potentially
regulated by c-Myc were identified. We explored a c-Myc regulatory network in BASCs using a number of statistical and
computational approaches through two different strategies; 1) c-Myc/Max binding sites within individual gene promoters,
and 2) miRNA-regulated target genes.
Results: c-Myc expression was upregulated in BASCs and downregulated over the time course of lung organogenesis in
vivo. The depletion of c-Myc in BASCs resulted in decreased proliferation and cell death. Multiple mRNAs and miRNAs were
dynamically regulated in c-Myc depleted BASCs. Among a total of 250 dynamically regulated genes in c-Myc depleted
BASCs, 57 genes were identified as potential targets of miRNAs through miRBase and TargetScan-based computational
mapping. A further 88 genes were identified as potential downstream targets through their c-Myc binding motif.
Conclusion: c-Myc plays a critical role in maintaining the self-renewal capacity of lung bronchoalveolar stem cells through a
combination of miRNA and transcription factor regulatory networks.
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Introduction
Bronchoalveolar stem cells (BASC) were recently identified in
adult mouse lung as a rare cell population located in the
bronchoalveolar duct junction [1,2]. They were identified and
purified by FACS based on being positive for Sca-1 and CD34 and
negative for CD45 and CD31. This population was also
characterized by its double positive staining characteristics for
both the alveolar epithelial type II (AT2) cell marker, surfactant
protein C (SP-C), and the Clara cell marker, Clara cell secretary
protein (CCSP). BASCs demonstrated resistance to naphthalene-
induced lung injury and were activated by the oncogenic protein
Kras. Viable BASCs were maintained through multiple passages
in vitro under distinct culture conditions, and retained the ability
to differentiate into either Clara cells or alveolar type II cells AT2
[1,3,4]. The observation that almost all cells in the epithelium of
the smaller distal airways during early embryonic lung develop-
ment (E13–E15) express markers of AT2s and Clara cells [5]
supports the potential existence of BASCs that are maintained into
adulthood once development is complete.
The identification of BASCs has made it possible to begin to
map out the pathways that are required for adult progenitor or
stem cell function in lung morphogenesis and lung tumorigenesis.
Using p38a conditional lung knockout mice, Ventura et al [6]
found that inactivation of p38a leads to an immature and
hyperproliferative lung epithelium that is highly sensitized to
Kras-induced tumorigenesis with coincident expansion of the
BASC population. Dovey et al [7] demonstrated that loss of Bmi1
decreases the number and progression of lung tumors with
deficient proliferation of BASCs in a Kras-initiated lung cancer
model. Yanagi et al [8] generated PTEN knockout mice under
control of the SP-C promoter where 90% of mice that received
doxycycline in utero died of hypoxia soon after birth. Postnatal
deletion of PTEN resulted in spontaneous lung adenocarcinomas
with increased BASC numbers. Zhang et al. [9] showed that
deletion of Gata6 resulted in the expansion of the BASC
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activation of the canonical Wnt signaling pathway. These
molecular mechanisms regulating the balance between BASC
expansion and epithelial differentiation and regeneration suggest
that the process of lung tumorigenesis may share critical common
pathways with lung organogenesis and response to lung injury.
Stem cells are vital to all stages of life. During early embryo-
genesis, pluripotent embryonic stem cells (ESCs) differentiate to give
rise to the three germ layers that establish the basic vertebrate body
plan. As development proceeds, distinct subsets of stem cells emerge
to orchestrate the construction of tissues and organs. Once tissues
are fully established, stem cells undergo a fundamental change as
their role turns from tissue building to tissue maintenance and
repair, which persists throughout adult life [10,11]. The unique
ability of ESCs and adult tissue stem cells to self-renew and give rise
to multiple cell lineages has formed the basic definitions of
‘‘stemness.’’ We hypothesized that portions of the core transcrip-
tional program of ‘‘stemness’’ present within ESCs may also be
shared within putative adult stem cell types such as BASCs. We
explored potential underlying mechanisms for maintaining the self-
renewal capacity of BASCs by screening stemness transcription
factors among 34 genes from a transcription network for
pluripotency in ESCs, along with 19 genes from candidates for
reprogramming fibroblasts into a pluripotent embryonic stem cell-
like state [12,13]. We found that c-Myc is the most prominent
transcription factor upregulated in BASCs, with increased expres-
sion in BASCs, Kras-initiated lung tumors, and early lung
developmental stages compared with normal adult lung.
Myc is a global transcriptional factor, binding E-box elements
(with its partner Max) to regulate gene transcription [14]. Myc can
bind to sites covering up to approximately 10–15% of the genome
and can regulate thousands of genes. c-Myc is highly expressed in
many normal proliferating cells and in cancer. It plays a critical
role in regulating cell growth, proliferation, loss of differentiation,
and apoptosis [14,15]. In transgenic mice, targeted overexpression
of c-Myc has been shown to be sufficient to induce cancer
[16,17,18]. In the lung, Myc overexpression in alveolar epithelium
results in the development of adenocarcinoma [19], while
inhibition of Myc triggers rapid regression of incipient and
established Ras-induced lung adenocarcinoma [20]. c-Myc
controls two large independent sets of target genes. One set of
target genes is transcriptionally regulated by binding of the c-Myc/
Max complex to E-Boxes in target gene promoters. Another set of
target genes are post-transcriptionally repressed by Myc-induced
miRNAs [21].
In this study, we utilized a loss-of-function approach to explore
the potential role of c-Myc in the self-renewal of mouse BASCs
through a combination of miRNA and transcription factor
regulatory networks.
Results
BASC isolation and CCA
+/SP-C
+ double staining
The synthesis of SP-C is a unique feature of AT2 cells and is
commonly used to identify these cells from other lung parenchy-
mal cells. CCA, also known as CC10 or CCSP, has been widely
used as a marker for Clara cells. Previous studies have shown that
CCA
+ SP-C
+ double-positive cells located in the bronchoalveolar
duct junction are a putative pulmonary stem cell population in the
adult mouse lung. These cells, referred to as BASCs, were
originally described as positive for CD34 and Sca1 and negative
for CD31 and CD45.





(Figure 1A) and plate onto irradiated MEF cells in BASC media.
After the population was established, cells were cultured on
collagen-coated dishes and subcultured every 7 days at a density of
1:20 in BASC media (Figure 1B). To confirm these cells
subcultured for several generations still maintain the original
marker profile, double immunostaining of CCA and SPC were
performed. The expression of both SP-C (red) and CCA (green)
were detected in the cytoplasm of the majority of cell colonies, as
expected, even after multiple passages in culture (Figure 1C).
In addition to colony formation and proliferation, BASCs
retained their capacity for differentiation in serial culture. To
obtain differentiation of BASCs, the cells were cultured in SAEM
media. Immunophenotyping with CCA, SP-C and Aquaporin-5, a
marker of AT1 cells, confirmed the multilineage differentiation
capacity of BASCs. Differentiated cells including Clara-like cells
(CCA
+ SP-C
2), AT2-like cells (SP-C
+CCA
2) and AT1-like cells
(Aquaporin
+) were all present with removal of LIF and growing
cells in SAEM media (Figure 1D).
Screening of ‘‘stemness’’ transcription factors in BASCs
Considering the unique ability of embryonic stem cells (ESCs)
and adult tissue stem cells to self-renew and give rise to multiple
cell lineages, we hypothesized that some or many of the known
members of the core transcriptional program for ‘‘stemness’’
would also be present in BASCs. We identified common genes by
screening a total 53 transcription factors, including 34 genes from
a transcription network for pluripotency of ESCs [12], and 19
genes from candidates for reprogramming fibroblasts into a
pluripotent embryonic stem cell-like state including Oct4, Nanog,
c-Myc and Sox2 [13].
Statistically significant differences in gene expression are shown
in figure 2. Compared with normal lung tissue, 6 genes (c-Myc,
Trim28, Mybbp1a, BAF155, Prmt1, Btbd14a) were increased and
6 genes (Klf4, b-Catenim, Rif1, Pelo, Arid3b, Sox2) were
decreased in BASCs (Figure 2A). BAF155, c-Myc, Mybbp1a,
Prmt1, Wdr18, Rif1 were increased, and Klf4, Stat3, and Pelo
were decreased during the time course of lung development
(Figure 2B). BAF155 and c-Myc were increased and Pelo, Esrrb,
Zfp609, Klf4, and Sox2 were decreased in K-ras lung tumors
compared with normal lung (Figure 2C). We found that c-Myc
was the only transcription factor increased in both BASCs and K-
ras-initiated lung tumors, and decreased longitudinally over the
time course of lung development.
Depletion of c-Myc inhibits proliferation of BASCs
To determine whether c-Myc is a critical factor for BASC
growth and survival, we depleted its endogenous expression by
transfecting lentivirus-delivered c-Myc shRNA into BASCs. We
observed that many BASCs died within 3 days following
transfection (Figure 3A). The number of viable cells was
downregulated 58% at day 3, and 62% at day 5 among two
different c-Myc shRNA constructs following transfection
(Figure 3B). After several generations of puromycin selection,
stable c-Myc knock down cell lines were established and the degree
of c-Myc reduction in both mRNA and protein level was
determined. We found that BASCs infected with control lentivirus
continued to proliferate logarithmically; in contrast, cells infected
with varying c-Myc shRNAs demonstrated dramatically reduced
proliferation rates (Figure 3C).
Identification of dynamically regulated mRNAs by c-Myc
in BASCs
To explore the molecular architecture of the c-Myc pathway in
BASCs, gene expression microarray analysis was performed. The
c-Myc Networks in BASCs
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groups (c-Myc depleted BASCs and wild type BASCs) were
obtained after normalization. Using a cut-off value of fold change
as .|2|, and a p-value for ANOVA analysis set as p,0.05, 316
dynamically regulated probes representing 250 unique genes were
identified. Among these, 131 genes were increased, and 119 genes
were decreased in comparing c-Myc knockdown cells with wild
type controls (Table S2).
To focus on the mechanisms that underlie the generation of this
c-Myc profile, including the genes induced or repressed by c-Myc,
we used the online biological classification tool DAVID to analyze
the significant enrichment of these genes for biological processes in
GO categories. We listed all GO terms (ranked by count number)
in each group with p,0.05 and fold enrichment .2. Genes with
increased expression in comparing c-Myc knockdown cells with
wild type controls were enriched for the terms development and
cell differentiation, while genes with decreased expression were
enriched for the terms cell cycle and regulation of cell migration
and locomotion (Figure 4).
Identification of miRNAs dynamically regulated by c-Myc
depletion in BASCs
To address a potential role for miRNAs in a c-Myc regulatory
program, miRNA expression profiling was performed using the
Taqman real-time PCR based method to screen 521 mouse
miRNAs. In total, the expression of 256 miRNAs was detected in
control and c-Myc depleted BASCs and their values normalized
using an internal control. For the expression data, a cut-off value
Figure 1. Characterization of BASCs. (A) Methodology of FACS sorting of BASC. First, cells were gated on the CD31
2 CD45
2 population, and




+ population (BASCs). (B) Phase-contrast images of clonal growth of BASCs on day 6 and
BASCs in culture after several generations in serial culture (2006). (C) Identification of BASCs by dual-color immunofluorescent staining for anti-SP-C
(red) and anti-CCA (green). (D) Differentiation of BASCs in SAEM media was identified by staining for anti-SP-C (red), anti-CCA (green) and anti-
Aquaporin (green).
doi:10.1371/journal.pone.0023707.g001
c-Myc Networks in BASCs
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.|2|. The p-value for ANOVA analysis was set as p,0.05. In
total, 17 miRNAs were identified through these criteria, the
expression of 14 miRNAs were upregulated, while 3 miRNAs were
downregulated in comparing the c-Myc knockdown group with
wild type (Figure 5A). Several members of the miR-17-92/106b
cluster including miR-17, miR-19b, miR-20a and miR106b were
increased.
Among these 17 dynamically regulated miRNAs, the top 5 with
the greatest fold change were miR-126 (23-fold), miR-34c (17-
fold), miR-130a (12-fold), miR-574 (9-fold) and miR-193b (8-fold).
The top 5 miRNAs with the highest expression values were miR-
19b, miR-125b, miR-17, miR-214 and miR-34b; miR-19b was
most substantially expressed with a copy number of 11,333 per
cell.
c-Myc transcriptional regulatory networks in BASCs
1) Identification of target genes regulated by
miRNA. Because each miRNA may negatively regulate
multiple mRNAs, we investigated whether those significantly
changed mRNAs regulated by c-Myc depletion resulted from the
regulatory effects of miRNAs. For this analysis, those mRNAs
downregulated under c-Myc depletion may be potential targets of
an individual miRNA up-regulated and vice versa. We then cross-
referenced these potential mRNA targets against the computa-
tionally predicted targets of the 17 miRNAs regulated by c-Myc
depletion from miRBase and TargetScan. In all, we identified 109
miRNA-mRNA probe pairs, involving 52 unique mRNAs from
miRBase, and 7 miRNA-mRNA probe pairs which included 6
unique mRNAs from TargetScan (Figure 5B). Similar to previous
results of such mapping for miRNA-mRNAs target pairs in normal
lung development [28], this would suggest that the TargetScan
database is more stringent with lower sensitivity than miRBase.
In our real-time PCR miRNA array data, miR-34a, miR-34b-
3p and miR-34c were increased when c-Myc was depleted in
BASCs (Figure 5C). MiR-34b-3p in particular was very highly
expressed and dramatically increased after c-Myc depletion. Based
on computational predictions from miRBase, there are a total of
11 potential target mRNAs for miR-34 within our data displaying
decreased expression. We evaluated a number of these potential
targets by real-time PCR. We found Plk4 (Polo-like kinase 4), Tnc
(Tenascin C), Usp1 (Ubiquitin specific peptidase 1) and Ipo7
Figure 2. Expression of stem cell transcription factors. (A) In BASCs. (B) In mouse lung in different developmental stages. (C) In K-ras mutant
activated lung tumor tissue. In total, expression of 53 stem cell transcription factors were measured including 34 genes from a transcription network
for pluripotency of embryonic stem cells [20], and 19 genes from candidates for reprogramming fibroblasts into a pluripotent embryonic stem cell-
like state [13] using quantitative real-time PCR. b-actin was used as an internal control. Statistically significant differences are shown. Values are means
6 SD of the fold increase compared with adult mouse lung (n=3).
doi:10.1371/journal.pone.0023707.g002
c-Myc Networks in BASCs
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array data (Figure 5D). Plk4 is necessary for cellular proliferation,
as alteration in Plk4 levels cause significantly adverse mitotic
defects including abnormal centrosome duplication and aberrant
mitotic spindle formation [29]. In the lung, Tnc appears at the
epithelial-mesenchymal interface during branching morphogenesis
where it may promote airway branching [30,31]. Usp1 depletion
impacts the stability and phosphorylation of Chk1 which is a cell
cycle regulated and DNA damage checkpoint protein [32]. Given
their known biological function, the downregulated expression of
these genes is consistent with our observation of impaired BASC
proliferation induced by c-Myc depletion.
Figure 3. Inhibition of c-Myc expression in BASCs. (A) BASCs were plated in 24-well plates at 40,000 cells per well and incubated in complete
medium overnight to achieve 50% confluence. BASCs were infected with viral supernatant including control shRNA or two different c-Myc shRNAs. At
day 3, day 5 and day 7 after infection, the cells were washed with PBS and images were taken under both normal light and blue light for GFP
expression. (B) BASCs were suspended and stained with trypan blue at the indicated time points. Stained cells were placed in a hemocytometer and
viable (unstained) cells were counted. Plotted values are the means 6 SD of three replicates. (C) After several generations of puromycin selection,
stable c-Myc knock down cell lines were established. c-Myc mRNA and protein expression were measured by real-time PCR and western blotting and
cells were counted at the indicated time points.
doi:10.1371/journal.pone.0023707.g003
c-Myc Networks in BASCs
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regulated mRNAs and miRNAs. A transcription factor
protein typically regulates downstream genes through binding
via a specific motif on the promoter of its target genes. To
ascertain potential direct downstream target genes of c-Myc by
identifying its binding sites, a position weight matrix (PWM) based
method MATCH (BKL TRANSFACH Pro) was used to perform
sequence similarity searches. We predicted c-Myc binding sites
from genomic sequences spanning 2 kb upstream of the
transcriptional start site (TSS) through the first exon for all 250
c-Myc-regulated genes we identified in BASCs using the ‘‘Best
supported’’ promoter method and p-value,0.01. In total, 208
different c-Myc/Max binding sites were found in 88 gene
promoters (Table S2). Although it is possible that c-Myc binding
sites may occur outside the regions we studied, the coverage was
determined from the knowledge that bona fide c-Myc binding sites
appear to cluster within 2 kb of the TSS, and there is a prevalence
of c-Myc binding sites in the first intron of many target genes
[33,34].
Discussion
In this study, we explored the dynamic transcriptional and post-
transcriptional regulatory mechanisms responsible for self-renewal
in bronchoalveolar stem cells. First, we successfully isolated BASCs





demonstrated their ability to maintain double staining of CCA and
SP-C with serial passage in culture. Through the hypothesis of a
common transcriptional regulatory network in embryonic and
other stem cell types, we identified c-Myc as a potential regulator
of self-renewal in BASCs. We showed that the depletion of c-Myc
in BASCs by infection with Myc shRNA lentivirus resulted in
decreased cell proliferation and cell survival rate. Comprehensive
miRNA and mRNA profiling was performed, and identified 17
miRNAs and 250 mRNAs significantly changed in expression level
with c-Myc depletion. Lastly, we explored a c-Myc transcriptional
and post-transcriptional regulatory network by examining a
combination of c-Myc direct binding with 59-promoter sequences,
and the role of miRNAs induced by Myc depletion subsequently
binding with the 39-untraslated region (UTR) of target genes.
Myc is necessary and sufficient to maintain self-renewal in
mouse embryonic stem cells [35], and together with Sox2, Nanog,
Klf4, form an important group of transcription factors capable of
reprogramming mouse and human fibroblasts to a iPS (induced
pluripotent stem cell) state indistinguishable from known charac-
teristics of embryonic stem cells [13]. Ectopic expression of Myc
inhibits the differentiation of ESCs, and inhibition of Myc induces
differentiation of ESCs [36]. Myc function in the inhibition of
differentiation and promotion of proliferation are present not only
in ESCs, but also in adult stem cells. It is hypothesized that the
activity of adult stem cells is essential to replenish mature cells
constantly lost due to normal tissue turnover. Myc overexpression
upsets this balance between self-renewal and differentiation,
leading to an expansion of stem cell pools and a concomitant
loss of all differentiated cell lineages in hematopoietic stem cells,
renal stem/progenitor cells and skin stem cells [36,37]. In our
study, Myc was highly expressed in BASCs, the developing lung,
and Ras-induced lung adenocarcinoma. Depletion of c-Myc in
BASCs led to decreased cell survival and a reduction in cell
Figure 4. c-Myc-regulated mRNA expression pattern and gene ontology analysis. (A) Heat map of significantly changed genes in BASCs
with and without c-Myc. (B). Analysis of enrichment of GO biological process categories for each expression pattern with p,0.05 and fold enrichment
.2 are listed (ranked by count number).
doi:10.1371/journal.pone.0023707.g004
c-Myc Networks in BASCs
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in BASCs will promote differentiation to AT1, AT2 and Clara
cells similar to the promotion of differentiation with c-Myc
depletion in ES cells. We did observe however that the mRNA
expression of differentiated lung epithelial markers including SP-
C, CCA and Aquaporin were unchanged in our array data,
suggesting that the incomplete depletion of c-Myc alone has no
effect on the differentiation of BASCs (data not shown).
Myc is a transcriptional factor, directly binding E-box elements
(with its partner Max) to regulate gene transcription [14]. In our
study, we identified 250 Myc-regulated genes in BASC cells.
Enrichment analysis of gene ontology terms indicated that
downregulated genes in comparing c-Myc knockdown cells with
wild type controls were associated with cell cycle and cell
migration functions, while upregulated genes were associated with
development and cell differentiation. Among these dynamically
expressed genes, 88 genes were identified that had at least one
binding site for Myc/Max complexes on their respective
promoters (Figure 6).
In addition to regulating protein coding mRNAs, accumulating
evidence demonstrates that Myc transcriptionally regulates
miRNAs [38]. Recent work suggests that Myc regulates a much
broader set of miRNAs than previously anticipated [39]. MiRNAs
are a class of small RNAs that regulate the expression of target
genes at the post-transcriptional level. They are first transcribed
from miRNA genes in the nucleus as pri-miRNAs, then
transported into the cytoplasm as hairpin structures where they
are cleaved to form mature single strand miRNAs. Mature
miRNAs are then recruited into nucleoprotein complexes called
RNA-induced silencing complexes (RISC). Based on the pairing of
miRNAs and their 39-UTR target sites, the complexes can inhibit
translation by either degradation of the mRNAs or by blocking
translation without degrading the targets [28,40].
In our study, through miRNA profiling, we identified 17 Myc-
regulated miRNAs in BASC cells in culture. We noticed that
several members of the miR-17-92/106b cluster, such as miR-17,
miR-19b, miR-20a and miR106b, were increased in expression
with depletion of Myc in BASCs. A number of studies have
demonstrated that the miRNAs in this cluster play roles in lung
development and lung cancer [41,42]. The potential mechanisms
involved may include activation of targets such as RbI2 E2F1-3,
and PTEN, all known cell cycle regulators [43,44]. However,
Carraro et al. suggests that the function of the miR-17-92 cluster
may be to maintain the structural homeostasis of developing lung
Figure 5. Expression patterns of c-Myc-regulated miRNA and miRNA targets. (A) Heat map of significantly changed miRNAs in BASCs with
and without c-Myc. (B) Targeted genes and the genes numbers for each individual miRNA identified through overlapping the potential targets from
the miRBase and TargetScan predicted mRNA targets (blue). (C) Effect of c-Myc on the expression of miR-34 family. (D) Relative expression of mRNA
targeted by miR-34-3p using real-time PCR (n=3, mean 6 SE).
doi:10.1371/journal.pone.0023707.g005
c-Myc Networks in BASCs
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inhibition of miR-17 did not produce an arrest of proliferation
[45]. Through comparison of miRNA and mRNA expression
profiles in lung development, previous work by our group
indicated that the cluster most likely plays a role in the later
stages of lung development after lung branching morphogenesis is
complete [28]. Our data from this study support the notion of the
miR-17-92/106b cluster having a role on inhibition of prolifer-
ation and promotion of differentiation.
The miR-34 family was first identified as transcriptional targets
of p53 [46,47]. MiR-34a is the most well characterized family
member and is transcribed from a locus separate from miR-34b/c
which is produced as a single primary transcript [48]. In our study,
three miR-34 members including miR-34a, miR-34b-3p and miR-
34c were increased with Myc depletion in BASCs, supporting the
concept that all three members have potent anti-proliferative
affects with miR-34a additionally promoting apoptosis [48,49]. In
our study, miR-26a was increased with depletion of Myc in
BASCs. It has been reported that miR-26 is transcriptionally
regulated by Myc and contributes to tumorigenesis [39].
Computational miRNA target prediction algorithms have been
developed based on common features of known miRNAs and their
mRNA target interactions. These have greatly facilitated the
search for miRNA targets, but computational miRNA target
prediction does not account for true cellular context and
physiologic factors [50] . For the current study, both miRBase
and TargetScan were used to predict direct miRNA targets by
comparing negatively correlated miRNA expression with compu-
tational predictions. Comparisons with TargetScan require
stringent seed pairing, and miRBase requires moderately stringent
seed pairing, but even perfect base pair matching does not
necessarily guarantee interaction between specific miRNAs and
target genes [51]. Wobble base pairs are often tolerated in target
sites [52]. Given these differences, we utilized results from both the
miRBase and TargetScan databases. In total, we identified 57
mRNA targets for 17 miRNAs through such an approach.
Interestedly, we found that 25 genes were overlapping between 57
miRNA-regulated genes and 88 genes which had Myc/Max
binding sites on their respective promoter. Of Myc-induced genes,
28% appeared to be regulated by Myc-induced miRNA,
suggesting these miRNAs may partially exert their function by
acting as rheostats to fine-tune gene expression (Table S2,
Figure 6).
In this study, we provide insight to how c-Myc might promote
cell proliferation and control cell fate in BASCs through both
transcriptional and post-transcriptional means. As a transcription
factor, Myc binds to E-box elements with its partner Max and
regulates the transcription of genes whose products function to
drive cell cycle progression and lung development. In addition to
regulating protein coding mRNAs, Myc also transcriptionally
regulated non-coding miRNAs with negatively correlated mRNA
expression and predicted target biding sites. This finding suggests a
Figure 6. Schematic representation of c-Myc regulating cell proliferation and controlling cell fate in BASCs through both
transcriptional and post-transcriptional pathways. The depletion of c-Myc in BASCs resulted in decreased proliferation and cell death. 250
mRNAs and 17 miRNAs were dynamically regulated in c-Myc depleted BASCs. The model (from our work and others) depicts c-Myc regulating
downstream gene expression through two distinct mechanisms. 1) Transcriptional level: c-Myc directly regulates mRNA transcription with its partner
Max through c-Myc/Max binding sites in the 59-flanking promoter region of target genes. 88 genes were identified as potential downstream genes
through a position weight matrix based method in conjunction with changes in mRNA level. 2) Post-transcriptional level: c-Myc indirectly regulates
mRNA and protein expression through miRNAs. Myc can regulate miRNA expression through c-Myc/Max binding sites [41], and we identified Myc-
regulated miRNAs by comparing the c-Myc depleted group with controls. The mature miRNA can then negatively regulate gene expression through
one of 2 mechanisms; a) by miRNA/mRNA binding and degradation, which is dependent on sequence complementarity between the miRNA and the
target mRNA (57 genes were identified as targets of miRNAs through miRBase and TargetScan-based computational mapping); or b) miRNAs
suppressing gene expression by blocking protein translation independent of changes in mRNA level [28,40].
doi:10.1371/journal.pone.0023707.g006
c-Myc Networks in BASCs
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result of Myc binding to miRNA promoters [39], with these
miRNAs subsequently modifying mRNA expression on a post-
transcription level.
Methods
Mice and tissue preparation
Approval of the study protocol was obtained from the Mayo
Clinic Institutional Animal Care and Use Committee with
protocol number A9807. All mice were maintained in a specific-
pathogen-free animal facility at Mayo Clinic and all animal
experiments were carried out according to the provisions of the
Animal Welfare Act, PHS Animal Welfare Policy, and the
principles of the NIH Guide for the Care and Use of Laboratory
Animals. Lungs of different development stages were isolated by
manual dissection with the aid of a dissecting microscope from
timed-pregnant ICR mice. Lung tumor tissue was derived from
somatic activation of mutant K-ras in a well-described line of
transgenic mice [22].
BASC isolation and culture
BASCs were isolated from the lungs of 4–6 week old ICR mice
according to established protocols [1]. Mice were sacrificed, and
their lungs were removed and cut into small pieces. Tissue
dissociation was performed by treating with dispase (Invitrogen) at
37uC for 20 minutes, then passing the lungs through a 70 mM
filter to obtain a single cell suspension. After washing with PBS
(phosphate buffered saline), cells were stained with Biotin-
conjugated anti-CD31 and anti-CD45, APC-conjugated strepta-
vidin, PE-conjugated anti-Sca1 (BD Pharmingen), and FITC-





pos cells on an Aria Flow
Cytometry machine. Sorted BASCs were plated onto irradiated
MEF (mouse embryonic fibroblast) cells with BASC media
(DMEM, L-glutamine, MEM Non-essential amino acids, Penicil-
lin/Streptomycin, b-mercaptoethanol, HEPES, fetal bovine se-
rum, and LIF). After the population was been established, cells
were cultured in BASC media and passaged every 7 days onto
MEFs.
BASC immunostaining
BASCs were stained with anti-SP-C and anti-CCA (1:500,
Santa Cruz) in PBS with 0.2% triton X-100 overnight at 4uC after
cells were fixed and blocked. After washing, BASCs were
incubated for 30 minutes with rhodamine conjugated donkey
anti-goat (Jackson Laboratories), followed by FITC donkey anti-
rabbit antibody for 30 minutes at room temperature. After
washing, DAPI nuclear staining was performed. The immuno-
staining of Aquaporin-5 (Calbiochem), a marker of AT1 cells, was
performed after BASCs were cultured in SAEM (small airway
epithelial media, CnT-34, CellNted) to allow differentiation for 28
days.
RNA isolation and assessment of stem cell transcription
factors
Total RNA was extracted from mouse embryonic stem cells
(R1, generous gift of Dr. Janet Rossant) by using Trizol Reagent
(Invitrogen). RNA was reverse-transcribed and standard RT-PCR
for the 53 genes described was performed (Invitrogen). PCR
products were run on agarose gels and the DNA band was cut and
purified using the QIAEX II Gel Extraction Kit (Qiagen). DNA
amount was subsequently measured using a DNA concentration
standard. Developing lung, lung tumor tissue, and cultured BASCs
were washed by PBS and total RNA extracted. After reverse-
transcribing, absolute quantitative real-time was performed using
Brilliant SYBR Green QPCR Master Mix (Stratagene) and the
PRISM 7900 system (Applied Biosystems) according to the
manufacturer’s instructions. After PCR, melting curves was
constructed to ensure elimination of nonspecific products. The
amount of mRNA was determined by comparing with the
standard curves and normalization by b-Actin. The primer
sequences utilized are listed in Table S1.
Lentiviral constructs and transfection
Mouse c-Myc shRNA lentiviral expression vectors (4 in total)
and a negative control vector were purchased from GeneCopoeia.
All vectors contained the stable cell line selection marker
puromycin and EGFP in the vector backbones. Among the 4
shRNA vectors, 2 vectors which targeted regions beginning at
1705 (ACGTCTTGGAACGTCAGAG) and 1923 (CAGCTTC-
GAAACTCTGGTG) nucleotides for the c-Myc mRNA sequence
(NM_010849.4) demonstrated the strongest inhibition of c-Myc.
293 FT cells were transfected in the presence of 10 ug packaging
plasmids (GeneCopoeia) and 2 ug of the Lentivirus expression
vectors using FuGENE 6 (Roche). Viral supernatants were
collected 48 hr after transfection, filtered through disposable
0.45 um cellulose acetate filters (Millipore) and frozen in
individual aliquots at 280uC.
BASCs were plated in 24-well plates at a density of 40,000 cells
per well and incubated in complete medium overnight to achieve
50% confluence. BASCs were then infected by removing the
culture medium and replacing it with 0.25 ml viral supernatant
and 0.25 ml complete medium in the presence of 8 ug/ml
polybrene (Sigma) for 24 hours. c-Myc knockdown stable BASC
cell lines were generated through puromycin (Sigma) selection.
Western blot Analysis
Immunologic detection of c-Myc with rabbit polyclonal c-Myc
antibody (Cell Signaling, 1:1000 dilutions) was performed. In brief,
20 mg total protein was loaded on an 8% polyacrylamide gel,
electrophoresed, and transferred to polyvinylidene diflouride
membranes, which were blocked with Tween-Tris–buffered salt
solution (TTBS) containing 5% skim milk. Membranes were
incubated overnight at 4uC with c-Myc antibody. After washing 3
times with TTBS, membranes were incubated with anti-rabbit
IgG-HRP for 1 hour at room temperature and images recorded.
mRNA and microRNA expression arrays
Messenger RNA expression profiling was performed using the
Affymetrix GeneChip Mouse Genome 430 2.0 Array containing
probes to query more than 39,000 transcripts. The reverse
transcription, labeling and hybridization of mRNA were per-
formed in the Mayo Microarray Shared Resource.
MiRNA expression profiling was performed using the Taqman
Rodent MicroRNA Array Card A and Card B (Applied
Biosystems) containing all 521 mature mouse miRNAs in miRBase
10.1 http://microrna.sanger.ac.uk. In brief, miRNA was reverse
transcribed to cDNA using the Megaplex TM RT Rodent Primers
Pool and the TaqMan MicroRNA Reverse Transcription Kit.
Quantitative 384 well TaqMan Low Density Array real-time PCR
was run on the ABI PRISM 7900 System using the TaqMan
Universal PCR Master Mix. Raw miRNA array data was
analyzed using RQ manager software on the ABI system. All
undetectable data and the data with CT values greater than 35
were treated as 35 [23]. Normalized CT (DCT) was calculated by
comparing each miRNA value to that of small nuclear U6 RNA.
The U6 RNA is a common internal control for each microRNA
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)/3.34/22 that was estimated using synthetic lin-4
miRNA [24]. Each profiling experiment is the result of 2
replicates. All array data have been submitted to the Gene
Expression Omnibus (GEO) database, with accession number
GSE30323 for mRNA and GSE30435 for miRNA data.
Data processing and analysis
Both mRNA and miRNA array data analyses were performed
with the Partek Genomics Suite 6.4 software. For mRNA
expression data, Affymetrix CEL files were imported. The data
were normalized with the Robust Multichip Average Algorithm
[25] and converted to log2 values. For miRNA expression data, the
DCT value was directly imported as a log2 value. The greater the
DCT value, the lower the miRNA expression value. Logged data
were used for hierarchical clustering and statistical analysis. After
eliminating genes with expression levels at or below background,
fold change and p-values derived from ANOVA analysis were
used to filter out significantly changed miRNA and mRNA probes.
We assumed that an individual upregulated miRNA may have
potential mRNA targets with downregulated expression. Over-
lapping these potential targets with the computational mRNA
targets of each miRNA retrieved from the miRBase (version 5) and
TargetScanMouse (5.1) databases, we identified a collection of
direct mRNA targets for each miRNA. The software package
g:Profiler was used to convert Transcript IDs from miRBase into
Affymetrix mouse 430 probe set IDs [26].
Gene ontology and promoter analysis
Using whole probe sets from the Affymetrix mouse 430 2.0
array as a reference gene list, gene ontology (GO) enrichment
analysis was performed using the Database for Annotation,
Visualization and Integrated Discovery (DAVID, National
Institutes of Health) [27]. The most widely used method for
recognition of TF binding sites is the application of positional
weight matrices (PWM) [19]. MATCH is a PWM based method
from BKL TRANSFACH Pro that was used for c-Myc binding site
analysis.
Supporting Information
Table S1 Primer sequences for real-time PCR.
(XLS)
Table S2 Significant genes altered by c-Myc depletion
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